ATKINSON KATHERINE COCCA enters EVOFEM BIOSCIENCES, INC. with 16.67K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/7/2022ACC: 0001618835-22-000135
Officer· Chief Commercial Officer
Since May 2022
16.67K
Baseline shares
100% direct
16.67K
Direct ownership
1 position
10.67K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned16.67K
Total
16.67K direct16.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.67K | Direct |
| Total | 16.67K | 16.67K direct |
Derivative Holdings2
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
6.67K
Shares owned
N/A
Exercise price
7.34
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
4K
Shares owned
N/A
Exercise price
6.27
Expiration
—
Exercise window
—
Total
Underlying
10.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock | 7.34 | — | — | 6.67K | N/A |
| Stock option (right to buy) Direct | Common Stock | 6.27 | — | — | 4K | N/A |
| Total | 10.67K | 0.00 | ||||